Chemotherapy drug outperforms remdesivir against SARS-CoV-2 in lab experiments: Study
PTI, Jan 3, 2021, 3:15 PM IST
Beijing: A chemotherapy medication originally developed to treat cancer could potentially be repurposed to inhibit the replication of the novel coronavirus and treat COVID-19, according to a study based on computer simulations and lab experiments.
The research, published in the journal PLOS Computational Biology, combined multiple computational techniques that simulate drug-virus interactions from different, complementary perspectives.
Using this hybrid approach, scientists from the Shenzhen Institutes of Advanced Technology in China, screened 1,906 existing drugs for their potential ability to inhibit replication of the novel coronavirus by targeting a viral protein called RNA-dependent RNA polymerase (RdRP).
The researchers identified four promising drugs, which were then tested against the SARS-CoV-2 virus in lab experiments.
They said two of the drugs, pralatrexate and azithromycin, successfully inhibited replication of the virus, and further lab experiments showed that pralatrexate more strongly inhibited viral replication than did remdesivir – a drug that is currently used to treat some COVID-19 patients.
However, the researchers said the chemotherapy drug may prompt significant side effects and is used for people with terminal lymphoma, so they added that immediate use for COVID-19 patients is not guaranteed.
But the research highlighted the importance of the new screening strategy to identify drugs that could be repurposed.
”We have demonstrated the value of our novel hybrid approach that combines deep-learning technologies with more traditional simulations of molecular dynamics,” said study author Haiping Zhang of the Shenzhen Institutes of Advanced Technology.
The researchers are now developing additional computational methods for generating novel molecular structures that could be developed into new drugs to treat COVID-19.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
BTS2024: If India can make rocket sensors, it can also make car sensors, says ISRO chief Somanath
World COPD Day: Know your lung function
SpaceX successfully launches ISRO’s 4,700 kg communication satellite from US
As AI and megaplatforms take over, the hyperlinks that built the web may face extinction
Plastic waste could double by 2050, researchers find, suggest policies to address issue
MUST WATCH
Latest Additions
BJP stages protest against Congress govt in Karnataka over Waqf properties row
Loyalty Remembered: Mangaluru Airport’s K9 hero Jack passes away
Waqf issue: BJP stages Namma Bhoomi Namma Hakku protest in Bengaluru
Bomb disposal squad tackles ‘security incident’ at UK’s Gatwick Airport
Baba Siddique murder: Man held from Akola, 26th arrest in case
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.